Barclays
GRCL

Barclays’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Barclays’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
2023
Q4 		$106K Sell
2023
Q3 		$898K Buy
2023
Q2 		$40K Sell
2023
Q1 		$376K Buy
2022
Q4 		$198K Buy
2022
Q3 		$125K Sell
2022
Q2 		$222K Buy